Clinical improvements in pruritus and disease severity were observed following 24 weeks of nemolizumab treatment among adults with moderate to severe prurigo nodularis. Adults with moderate to severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback